Results 1 to 10 of about 1,148 (155)
Kinetic Study of Lornoxicam Hydrolysis
Gastrointestinal tract (GIT) side effects due to the local action of lornoxicam considered the most common problem that associated with using of this analgesic drug.
sawsan hasan hammodi +1 more
doaj +5 more sources
Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design (QbD) Approach
The present study aims to design and optimize the lornoxicam dispersible tablet (LXDT) formulation using the Quality by design (QbD) approach. A randomized Box–Behnken experimental design was used to characterize the effect of the critical factors, such ...
Gamal Mahrous, Mohsin Kazi
exaly +3 more sources
Impact of Different Drying Processes on the Physico-Chemical Properties of Liquitablet Formulations Containing Lornoxicam [PDF]
Background: Enhancing bioavailability is the target of most pharmaceutical research; this can be achieved by modifying the physico-chemical characteristics of poorly water-soluble drugs intended for oral administration using different techniques.
Csilla Balla-Bartos +3 more
doaj +2 more sources
Safety of lornoxicam in G-6-PDH deficiency
Objective: To assess the safety of lornoxicam in subjects with G-6-PDH deficiency. Methods: Open controlled 2-week in vivo study on lornoxicam 8 mg bid in subjects with G-6-PDH deficiency suffering from rheumatic diseases.
G. Perpignano +3 more
doaj +5 more sources
Lornoxicam use to reduce the pain associated with propofol injection
Aim: To investigate the efficacy of lornoxicam in the prevention of the pain associated with propofol injection. Material and method: Approval for this study was granted by the ethics committee of our hospital.
Yakup Aksoy +2 more
exaly +2 more sources
Lornoxicam was practically water insoluble and a nonsteroidal anti-inflammatory therapeutic agent thus associated with gastrointestinal tract (GIT) side effects.
Hayder Kadhim Drais
doaj +1 more source
(1) Background: Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antiphlogistic and antipyretic effects. The improved tolerance of lornoxicam due to the relatively shorter elimination half-life in comparison to other members of
Jamal Hussen +5 more
doaj +1 more source
MUCOADHESIVE BUCCAL PATCHES OF LORNOXICAM: II– IN-VIVO EVALUATION AND CLINICAL EFFICACY [PDF]
Lornoxicam is a NSAID of the oxicam class and it has the same side effects of this groupwhen taken orally. In attempts to avoid the systemic side effects of lornoxicam (e.g.
Fawzia Habib +4 more
doaj +1 more source
Effect of Low Level Laser Therapy, Dex-amethasone, and Lornoxicam on Post-Operative Pain after Periapical surgery: A comparative clinical study [PDF]
To compare the effect of low level laser therapy ( LLLT), submucosal lornoxicam, and submucosal dexamethasone to control postoperative pain after periapical surgery of upper anterior teeth.
Waqass S. Thanoon , Omer W. Majid
doaj +1 more source

